pembrolizumab
merck
['hcc', 'keynote-224', 'pembro']
pembrolizumab monotherapy for previously untreated advanced hepatocellular carcinoma (ahcc): 3-year follow-up of the phase 2 keynote-224 study #asco22 
Medicina Interna - Oncología Clínica - Profesor Titular @UPBColombia - Clínica Astorga. #Medellín / #Colombia mlujanonco@gmail.com #OncTwitter #Metaanalysis